ProShares Ultra Profile

USD 0.48  0.81%

ProShares Ultra Summary

ProShares Ultra Nasdaq Biotechnology [BIB] is traded in USA and was established on February 20, 2018. The fund is classified under Trading--Leveraged Equity category within ProShares family. ProShares Ultra Nasdaq Biotechnology currently have 449.38 M in assets under management (AUM). , while the total return for the last 3 years was -3.12%.
Check ProShares Ultra Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ardsley Advisory PartnersCall Options1.8 M60.8 M
Susquehanna International Group LlpPut Options137.9 K7.7 M
Opus Point Partners Management LlcFund Units130.5 K7.3 M
View ProShares Ultra Diagnostics

ProShares Ultra Nasdaq Risk Profiles

ProShares Ultra Nasdaq Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. ProShares Ultra Nasdaq Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares Ultra price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

ProShares Ultra Against Markets

Current Ratings

ProShares Ultra 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 2% 
Equity ratings for ProShares Ultra Nasdaq Biotechnology are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the daily performance of the Nasdaq Biotechnology Index. ProShares Ultra is traded on NASDAQ General Markets in USA. more
NameProShares Ultra Nasdaq Biotechnology
Macroaxis Advice
InstrumentUSA Etf ETF Directory
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
Contact Number866 776 5125
CurrencyUSD - US Dollar
DescriptionProShares Ultra Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management417.01 Million
Average Trading Valume325,095
Asset TypeEquity
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Devin Sullivan
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.04
Management Fee0.75

Current Sentiment - BIB

ProShares Ultra Nasdaq Investor Sentiment
Greater number of Macroaxis users are currently bullish on ProShares Ultra Nasdaq Biotechnology. What is your perspective on investing in ProShares Ultra Nasdaq Biotechnology? Are you bullish or bearish?
98% Bullish
2% Bearish
Skip  Hide


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas